These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
Q4 earnings roundup: Raymond Realty, MCX among 19 companies that delivered 100%+ growth in sales and PATA select group of 19 large-cap BSE-listed companies achieved triple-digit growth in both profit and revenue during Q4FY26, indicating stron...
Geopolitical tensions keep markets nervous despite strong earnings: Dipan MehtaGeopolitical tensions, particularly the Iran crisis, are overshadowing strong corporate earnings, according to Dipan Mehta. While India Inc...
Neuland Laboratories shares rally 7% as profit jumps seven-fold and revenue doubles in Q4Neuland Laboratories shares saw a significant jump following a strong Q4 performance. The company reported a massive increase in profit and...
Vijay Kedia Portfolio Check: 10 stocks surge up to 44% — plus 5 fresh picksIn terms of CY26 price performance, the portfolio delivered mixed results, with 13 stocks posting positive returns, while the remaining hol...
Earnings season is strong, but Q1 pain is coming: Dipan MehtaMarket expert Dipan Mehta finds India's current earnings season strong. He notes that future quarters will test corporate India due to pote...
Small & midcaps rally! Wockhardt, Coforge, other stocks surge up to 14%. Do you own any?Smallcap and midcap stocks surged on Wednesday, outperforming broader market indices with gains of around 1% each. This rally was fueled by...
Two Trades for Today: A financial services major for an upmove of 7.85%, a mid-cap pharma stock for an almost 7% riseOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
Multibagger hunter Vijay Kedia buys 4.5% in SME Mahamaya Lifesciences; adds smallcap SPML Infra in Q4Ace investor Vijay Kedia boosted his smallcap exposure in Q4 by acquiring 4.53% in Mahamaya Lifesciences and 1.88% in SPML Infra. Kedia, kn...
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsWhat is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...
Positive Breakout: These 9 stocks cross above their 200 DMAsAs long as the stock is priced above the 200-day SMA on the daily timeframe, it is generally considered to be in an overall uptrend.
Neuland Laboratories shares jump 12% ahead of final dividendNeuland Laboratories shares are experiencing a surge, trading 12% higher. This increase comes as investors anticipate a final dividend of R...
Buy Neuland Laboratories, target Rs 1000: HDFC SecuritiesBuy Neuland Laboratories Ltd. at a price target of Rs 1000..